"Ipratropium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.
| Descriptor ID |
D009241
|
| MeSH Number(s) |
D02.145.074.722.229.400 D03.132.760.180.572.400 D03.132.889.180.648.400 D03.605.084.500.722.229.400 D03.605.869.229.400
|
| Concept/Terms |
Ipratropium- Ipratropium
- (endo,syn)-(+-)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane
- N-Isopropylatropine
- N Isopropylatropine
Ipratropium Bromide- Ipratropium Bromide
- Ipratropium Bromide Monohydrate
- Bromide Monohydrate, Ipratropium
- Monohydrate, Ipratropium Bromide
|
Below are MeSH descriptors whose meaning is more general than "Ipratropium".
Below are MeSH descriptors whose meaning is more specific than "Ipratropium".
This graph shows the total number of publications written about "Ipratropium" by people in this website by year, and whether "Ipratropium" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ipratropium" by people in Profiles.
-
COVID-19, severe asthma, and biologics. Ann Allergy Asthma Immunol. 2020 09; 125(3):357-359.e1.
-
Case report: Paradoxical responses to short acting beta-agonists in a pediatric patient. J Asthma. 2021 02; 58(2):213-215.
-
The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD. Eur Respir J. 2018 11; 52(5).
-
Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies. Pulm Pharmacol Ther. 2018 02; 48:71-79.
-
Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study. Int J Chron Obstruct Pulmon Dis. 2017; 12:2001-2014.
-
Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease. EBioMedicine. 2017 May; 19:139-145.
-
Two cases of severe obstructive pneumonia associated with an HKU1-like coronavirus. Eur J Med Res. 2007 Mar 26; 12(3):134-8.
-
Cold-induced rhinitis in skiers--clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. Am J Rhinol. 2001 Sep-Oct; 15(5):297-301.